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Abstract
Introduction—Despite the considerable overlap of asthma and chronic obstructive pulmonary 
disease (COPD), the extent to which the two diagnoses are the manifestations of the same disease 
remains unresolved. We conducted these analyses to evaluate the role of active asthma in the 
prevalence of physician-diagnosed COPD.
Methods—From 2006 through 2010, 74,209 adults aged 18–99 years and with a history of 
asthma participated in the Behavioral Risk Factor Surveillance System (BRFSS) Asthma Call-
back Survey and responded to interview-administered questionnaires via telephone. We used 
publicly available data from 71,639 (97%) participants to identify respondents with and without 
active manifestations of asthma and self-reported, physician-diagnosed COPD. We generated 
population-weighted estimates of physician-diagnosed COPD prevalence and conducted linear 
regression to estimate associations between active asthma status and the prevalence of COPD 
among current smokers, former smokers, and lifetime nonsmokers separately.
Results—Physician-diagnosed COPD was reported in an estimated 29% of the population with 
any history of asthma, including both active and inactive asthma. Age-specific prevalences of 
physician-diagnosed COPD were consistently higher among adults with active asthma than adults 
without active asthma. Compared to inactive asthma, active asthma was associated with an 8.3% 
[95 % confidence interval (CI) 6.1, 10.5] higher prevalence of physician-diagnosed COPD among 
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lifetime nonsmokers, a 20.6% (95 % CI 18.0, 23.3) higher prevalence among former smokers, and 
a 26.7% (95 % CI 22.5, 30.9) higher prevalence among current smokers.
Conclusions—Among adults with a history of asthma, active manifestations of asthma may 
play an important role in the epidemiology of COPD.
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Introduction
Asthma and chronic obstructive pulmonary disease (COPD) are common respiratory health 
conditions. Recent estimates in the United States indicate that in 2010, 11% of children 5–14 
years of age, 9% of individuals 15–34 years of age, and 8% of adults aged 35 and older 
experienced current asthma [1]. The same year, nearly 6% of adults aged 25 years and older 
reported physician-diagnosed COPD, with the percentages increasing to 10% among adults 
65 years and older [2]. The co-occurrence of asthma and COPD diagnoses, often referred to 
as ‘overlap syndrome,’ is well described, especially at older ages [3–8].
Despite the substantial overlap, the extent to which the two diagnoses are manifestations of 
the same disease or distinct entities remains unresolved [4, 6, 7, 9–15]. Asthma affects 
individuals at younger ages, whereas COPD occurs at older ages [1, 2]. Asthma is associated 
with eosinophilic inflammation, whereas COPD is associated with neutrophilic 
inflammation [15]. Common risk factors for both asthma and COPD include outdoor air 
pollution and occupational exposures [16–19], though cigarette smoking continues to be the 
most well-described, modifiable risk factor for COPD [20]. A history of asthma itself has 
been associated with the increased risk of COPD [21] and accelerated lung function decline 
[22, 23]. In a 20-year follow-up study by Silva et al. [21], individuals with active asthma 
were found to be at increased risk of developing symptoms of chronic bronchitis, being 
diagnosed with emphysema, and fulfilling criteria consistent with COPD than were 
individuals with inactive asthma or no asthma history, even after adjustment for age, sex, 
and smoking history. The fact that individuals with active asthma are at increased risk of 
developing COPD relative to individuals with inactive asthma suggests that asthma control 
may affect the occurrence of COPD.
Improving our understanding of the burden of COPD among adults diagnosed with asthma 
may provide insight into the role of asthma control in the observed overlap between asthma 
and COPD. We conducted these analyses to examine the prevalence of physician-diagnosed 
COPD among adults with a history of asthma using data collected routinely for surveillance 
of asthma in the United States. We report age-specific prevalences of COPD among adult 
respondents in the Behavioral Risk Factor Surveillance System (BRFSS) Asthma Call-back 
Survey with and without active asthma and across categories of cigarette smoking history.
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We conducted these analyses using data from the 2006–2010 BRFSS adult Asthma Call-
back Surveys. The BRFSS is a state-based, random-digit-dial telephone survey of men and 
women aged 18 years and older conducted annually in the United States [24]. The Asthma 
Call-back Survey is a follow-up telephone survey conducted approximately two weeks after 
the BRFSS among respondents who indicated that they have ever had asthma by responding 
“yes” to the following question: “have you ever been told by a doctor, nurse, or other health 
professional that you had asthma?” The BRFSS Asthma Call-back Survey is exempt from 
Institutional Review Board (IRB) review at the Centers for Disease Control and Prevention; 
state-specific IRB requirements apply to each of the participating states, the District of 
Columbia, and Puerto Rico.
Study Sample
We pooled the data collected from BFRSS Asthma Call-back Surveys conducted in 2006, 
2007, 2008, 2009, and 2010. The pooled sample included data from 42 geographic areas of 
the United States (40 states, the District of Columbia, and Puerto Rico). In the participating 
areas included in our analysis, the Council of American Survey and Research Organization 
response rates ranged from 41 to 71% in 2006, 36 to 72% in 2007, 35 to 68% in 2008, 36 to 
66% in 2009, and 31 to 67% in 2010 [25–27]. Because the Asthma Call-back Survey was 
not conducted in each geographic area during all 5 years, this analysis includes 22 
geographic areas for which 5 years of data were available (Arizona, California, Connecticut, 
District of Columbia, Georgia, Hawaii, Indiana, Iowa, Kansas, Maine, Maryland, 
Massachusetts, Michigan, Montana, Nebraska, New Hampshire, New York, Oregon, Texas, 
Vermont, Washington, and Wisconsin), 9 states for which 4 years of data were available 
(Florida, Illinois, Missouri, Nevada, New Mexico, Ohio, Oklahoma, Utah, and West 
Virginia), 3 states for which 3 years of data were available (New Jersey, North Dakota, and 
Rhode Island), 6 geographic areas for which 2 years of data were available (Alaska, 
Colorado, Louisiana, Pennsylvania, Virginia, and Puerto Rico), and 2 states for which 1 year 
of data was available (Alabama and Mississippi). Pooling these data resulted in 74,209 
respondents; we then excluded respondents who did not provide information about 
physician-diagnosed COPD status, cigarette smoking status, age, educational attainment, 
race/ethnicity, or sex, resulting in a sample of 71,639 respondents (Fig. 1).
Physician-Diagnosed COPD
We adhered to existing definitions to identify respondents with self-reported, physician-
diagnosed COPD status [2, 28–31]. Briefly described, the respondents were identified as 
having self-reported, physician-diagnosed COPD if responses were positive to any of the 
following three questionnaire items: “Have you ever been told by a doctor or health 
professional that you have chronic obstructive lung disease, also known as COPD?”; “Have 
you ever been told by a doctor or other health professional that you have emphysema?”; and 
“Have you ever been told by a doctor or other health professional that you have chronic 
bronchitis?” Self-reported, physician-diagnosed COPD is hereafter referred to as “physician-
diagnosed COPD.”
Mirabelli et al. Page 3













Identification of Active Asthma Among Adults with a History of Asthma
As described above, each Asthma Call-back Survey respondent was selected because of a 
positive response during BRFSS data collection about having been told by a doctor, nurse, 
or other health professional that he/she had asthma; thus, all respondents are considered to 
have a history of physician-diagnosed asthma. As in previous analysis of Asthma Call-back 
Survey data [32, 33], we categorized respondents as having active asthma if they reported 
that at least one of the following occurred during the past 12 months: talked to a doctor or 
other health professional about [his/her] asthma, took asthma medication, or experienced 
any symptoms of asthma. The remaining respondents, those without active asthma, are 
hereafter referred to as having inactive asthma. Following our main analysis, we conducted a 
secondary analysis in which we further restricted the categorization of active asthma to 
include only those respondents who reported experiencing any symptoms of asthma during 
the past 12 months.
Other Covariates
Each respondent self-reported his/her age, race/ethnicity, sex, educational attainment, and 
cigarette smoking status. Each respondent’s cigarette smoking status was categorized as 
current smoker, former smoker, or lifetime nonsmoker.
Statistical Analysis
Before pooling data from 2006–2010, we evaluated variation in the estimated prevalences of 
the variables of interest across the five survey-year period using the Rao-Scott Chi-square 
test, a design-adjusted variation of the goodness-of-fit test for equal proportions [34]. The 
resulting test statistics for active asthma (Χ2 = 3.80, 4 degrees of freedom [df], p = 0.43), 
physician-diagnosed COPD (Χ2 = 7.66, 4 df, p = 0.11), current smoking (Χ2 = 1.42, 4 df, p 
= 0.84), former smoking (Χ2 = 6.28, 4 df, p = 0.18), and lifetime nonsmoking (Χ2 = 7.28, 4 
df, p = 0.12) did not indicate differences at α = 0.05 in the proportion of respondents in each 
category across the 5-year period; therefore, we pooled the 5 datasets and present 
characteristics of the pooled 2005–2010 samples and the weighted population estimates.
To generate weighted population estimates, we used adjusted sampling weights that account 
for BRFSS and Asthma Call-back Survey nonresponse and unequal sampling probabilities. 
Unadjusted annual sampling weights were provided with the Asthma Call-back Survey data. 
Because we pooled data collected from 2006 through 2010 and because the number of 
geographic areas with Asthma Call-back Survey varied from year to year, we adjusted the 
sampling weights in each geographic area by dividing the unadjusted weight by the number 
of years for which data were available from that geographic area. We estimated prevalence 
of physician-diagnosed COPD within categories of age and across strata of active asthma 
and smoking status. We used linear regression to estimate associations between active 
asthma status and the prevalence of physician-diagnosed COPD. For this analysis, a single 
linear regression model was adjusted for age as a continuous variable centered at 44 years, 
educational attainment, race/ethnicity, sex, smoking status, and an interaction of active 
asthma status and smoking status. Results are presented as prevalence differences (PD), with 
95% confidence intervals (CI), indicating estimated changes in the prevalence of physician-
diagnosed COPD on the absolute scale. Estimated changes in prevalence between the 
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populations with active asthma and inactive asthma are shown separately for current 
smokers, former smokers, and lifetime nonsmokers. All analyses were conducted using 
procedures for analysis of complex sample survey data in SAS version 9.3 (SAS Institute 
Inc., Cary, North Carolina, USA). Results based on fewer than 50 unweighted respondents 
(i.e., percentages based upon a denominator <50) or for which the relative standard error is 
greater than 30% are not reported or interpreted.
Results
Table 1 shows characteristics of the 71,639 Asthma Call-back Survey respondents, 
estimated to represent nearly 26.4 million adults with a history of asthma, including active 
and inactive asthma. In this population, an estimated 72% were identified as having active 
asthma and an estimated 29% were identified as having physician-diagnosed COPD. Among 
those with active asthma, the estimated prevalence of physician-diagnosed COPD was 
34.6% (95% CI: 33.7, 35.6); among the remaining 28% with inactive asthma, the estimated 
prevalence of physician-diagnosed COPD was 14.7% (95% CI: 13.4, 15.9). Among 
respondents with active and inactive asthma, unadjusted percentage of respondents with 
physician-diagnosed COPD increased across categories of age; age-specific percentages 
were consistently highest among current smokers and lowest among lifetime nonsmokers 
(Fig. 2).
Adjusted associations between respondent characteristics, including active compared to 
inactive asthma status, and the prevalence of self-reported, physician-diagnosed COPD are 
shown in Table 2. Adjusted for age, educational attainment, race/ethnicity, and sex, active 
asthma was associated with a 26.7% (95% CI: 22.5, 30.9) higher prevalence of physician-
diagnosed COPD among current smokers, a 20.6% (95% CI: 18.0, 23.3) higher prevalence 
among former smokers, and an 8.3% (95% CI: 6.1, 10.5) higher prevalence among lifetime 
nonsmokers. In this adjusted model, the prevalence of physician-diagnosed COPD was 4.6% 
(95% CI: 3.0, 6.2) higher among female respondents than among male respondents and PDs 
decreased monotonically with increasing educational attainment (Table 2).
When we restricted our categorization of active asthma to include only those respondents 
who reported experiencing any symptoms of asthma during the past 12 months, we excluded 
5,769 respondents who were previously categorized as having active asthma, but who only 
reported talking to a doctor or other health care professional about his/her asthma or taking 
asthma medication during the past 12 months. Following this restriction, relative to inactive 
asthma, active asthma was associated with a 27.6% (95% CI: 23.3, 31.9) higher prevalence 
of physician-diagnosed asthma among current smokers, a 21.9% (95% CI: 19.2, 24.7) higher 
prevalence among former smokers, and an 8.8% (95% CI: 6.7, 11.0) higher prevalence 
among lifetime nonsmokers (not shown).
Discussion
We analyzed data from the 2006–2010 Asthma Call-back Surveys and found higher 
prevalences of physician-diagnosed COPD among adults with active asthma than among 
adults with inactive asthma. These higher prevalences were observed among current and 
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former smokers as well as lifetime nonsmokers, suggesting an important role for active 
asthma in the epidemiology of COPD in each category of smoking status.
Our findings complement recent estimates of COPD prevalence (e.g., age-adjusted 
prevalence: 6.5%; unadjusted prevalence: 6.8%) [2] and extend evidence from prospective, 
observational studies suggesting that knowledge of asthma history may provide information 
about the risk of COPD. Specifically, greater annual declines in FEV1 have been observed 
among individuals with self-reported asthma than among those without self-reported asthma, 
including among both smokers and nonsmokers [22]; greater age-related declines in FEV1 
have been reported among participants with asthma and among cigarette smokers [23]; and 
elevated risks of COPD have been reported among adults with active asthma and among 
current smokers [21]. Our findings build on this evidence by using public health surveillance 
data that are collected annually to examine whether the relationship between asthma and 
physician-diagnosed COPD can be observed in a large, cross-sectional population-based 
sample. The use of public health surveillance data has been identified as a priority for 
advancing the prevention and control of COPD [35]. Analysis of such data sources may 
provide useful information about modifiable factors (e.g., level of asthma control and 
smoking status), non-modifiable factors (e.g., age and sex), and other characteristics (e.g., 
educational attainment) associated with the prevalence of physician-diagnosed COPD.
In these analyses, we identified respondents as having active asthma based on positive 
responses about having talked to a doctor or other health professional about [his/her] asthma 
(estimated prevalence: 51%), taken asthma medication (estimated prevalence: 58%), and 
experienced any symptoms of asthma (estimated prevalence: 64%) during the past 12 
months. When we restricted our categorization of active asthma to include only those 
respondents who reported experiencing any symptoms of asthma during the past 12 months, 
the associations between active asthma and the prevalence of COPD were approximately 1% 
higher than those observed in our main analysis, where the definition of active asthma 
included talking to a doctor or other health care professional about asthma or taking asthma 
medication during the past 12 months. The small change following this restriction suggests 
that the associations observed in all three categories of smoking status are only modestly 
attenuated by the outcomes of discussions with doctors or other health care providers or 
asthma medication use during the past 12 months. In these data, just 4% were categorized as 
having active asthma by only having talked to a doctor or other health professional about 
asthma during the past 12 months and just 1% were categorized by only having taken 
asthma medication during the past 12 months. Using these public health surveillance data, 
we were unable to identify whether symptoms reported during the past 12 months improved 
following discussions with doctors or health professionals or use of medications for asthma, 
among individuals who reported these factors. Additional analyses conducted among 
populations responding to similar questions at intervals longer than 12 months apart may 
provide useful data about the contributing roles of health care visits and asthma medications 
in defining active asthma. Similarly, additional analyses conducted in the Asthma Call-back 
Survey or other surveillance data may further improve our understanding of how changes in 
medications and treatment practices, advances in patient education and self-management 
methods, and trends in second-hand smoke exposures and cigarette smoking may affect the 
relationship between asthma and COPD.
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We analyzed cross-sectional data and do not have in-depth information about factors that 
may be involved in the development of asthma, COPD, or both. Indeed, because we 
analyzed surveillance data, we cannot draw conclusions about or contribute to the discussion 
of whether there exists a causal relationship between asthma and COPD. A major limitation 
of these data is the lack of information about the extent to which asthma or COPD may have 
been incorrectly diagnosed or reported; neither the BRFSS nor the Asthma Call-back Survey 
include means by which the responses may be validated. A comparison of self-reported 
asthma to asthma classification based on physiologic measures during a clinical exam 10 
years earlier has shown that the validity of self-reported asthma varies with asthma severity 
[36, 37]. In the absence of clinical measures of asthma, participants in survey research are 
often asked whether they have been told by a doctor, nurse, or other health care provider that 
they have asthma. Data collected via self-administered questionnaire can be a reliable source 
of information about asthma [38]; the extent to which validity and reliability of asthma 
history information collected via interviewer-administered telephone survey are different 
from validity and reliability of the same information collected via self-administered 
questionnaire is unknown. Comparable data evaluating the validity and reliability of 
physician-reported COPD or the magnitude of recall bias affecting self-report of physician-
diagnosed COPD are also unavailable. We reiterate that in these data, self-reported, 
physician-diagnosed COPD status is considered a proxy for actual disease status. Similarly, 
self-reported smoking status is considered a proxy for actual smoking status and additional 
description of current and former smoking habits, such as pack-years of cigarettes smoked, 
is not available in these data. Information about self-reported smoking status cannot be used 
to make inferences about the extent to which the prevalence of physician-diagnosed COPD 
varies within groups, such as among occasional smokers, smokeless-tobacco users, 
individuals exposed to secondhand tobacco smoke, and those who quit smoking recently 
versus those who quit long ago, or across categories of pack-years of smoking history.
The large size of the pooled annual survey samples allowed us to evaluate the prevalence of 
physician-diagnosed COPD within strata of smoking status. We examined an alternate 
statistical method to adjust sampling weights; revising our analyses with alternate weights, 
computed by multiplying the proportion of respondents in each survey year by the 
corresponding survey year’s weight, as in previous analyses of Asthma Call-back Survey 
data [39, 40], did not markedly affect our results or conclusions (data not shown). Pooling 
data collected over five years provided a sufficiently large sample to enable us to evaluate 
the prevalence of physician-diagnosed COPD in nonsmoking and young adults, where the 
prevalences of COPD are relatively low, and in the sparsely populated category of current 
smokers with inactive asthma. Improving our understanding of the influence of active 
manifestations of asthma, including recent asthma symptoms, on long-term respiratory 
health may improve our growing understanding of the epidemiology of COPD. Indeed, 
cigarette smoking continues to be the most well-described, modifiable risk factor for COPD 
[20], and smoking prevention efforts continue to be identified as the highest priorities to 
reduce the onset of new COPD and exacerbation of existing COPD [41]. These findings 
highlight the importance of appropriate management of asthma among smokers and 
nonsmokers alike.
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The Asthma Call-back Survey is jointly administered with the Office of Surveillance, Epidemiology and 
Laboratory Services, Division of Behavioral Surveillance; data collection is managed by BRFSS coordinators in 
each of the participating states, the District of Columbia, and Puerto Rico.
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Selection of the survey respondents: 2006–2010 Asthma Call-back Survey. 1self-reported, 
physician-diagnosed COPD
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Age-specific estimated prevalences of physician-diagnosed COPD by smoking history 
among adults with active asthma (panel A) and inactive asthma (panel B). Estimates based 
on fewer than 50 unweighted respondents or for which the relative standard error is greater 
than 30% are not shown
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Table 2
Associations between respondent characteristics and the prevalence of self-reported, physician-diagnosed 
COPD among 2006–2010 Asthma Call-back Survey respondents
Characteristic PD (95% CI)a
Age, per year 0.6 (0.6, 0.7)
Educational attainment
  Less than high school 18.5 (15.5, 21.6)
  Graduated high school 13.0 (10.8, 15.2)
  Some college/technical school 7.5 (5.8, 9.2)
  Completed college/technical school 0.0 (referent)
Race/ethnicity –b
Sex
  Female 4.6 (3.0, 6.2)
  Male 0.0 (referent)
Smoking status
 Current smoker
  Active asthma 26.7 (22.5, 30.9)
  Inactive asthma 0.0 (referent)
 Former smoker
  Active asthma 20.6 (18.0, 23.3)
  Inactive asthma 0.0 (referent)
 Lifetime nonsmoker
  Active asthma 8.3 (6.1, 10.5)
  Inactive asthma 0.0 (referent)
a
Prevalence differences (with 95% confidence intervals) generated from a single model including all covariates shown in the table
b
Race/ethnicity is included in the model; however, relative standard errors are greater than 30%; therefore, the results are not shown or interpreted
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